European Cancer Organisation – ECO shared on LinkedIn:
“€228 billion. That is the cost of cancer for 31 European countries, combining healthcare expenditure and lost productivity.
Investing in cancer control saves lives. But it also makes economic sense. Our new paper on investing in cancer care, presented during the session, shows just that.
- OECD modelling suggests that tackling major risk factors could prevent around 300,000 cancer cases and save €61 billion in healthcare costs every year, including from related diseases
- Treating cancer at an early stage can cost two to four times less than treating advanced disease
- A Dutch study estimated that a return-to-work programme for cancer survivors could generate €92 million a year in productivity gains, for just €15.4 million in costs
During the session, experts, decision-makers and stakeholders explored why cancer care should be seen as an investment rather than a cost, with benefits for workforce participation, productivity, equity and health system resilience.
‘Europe is aging and cancer is a disease that comes with old age. This is only going to get worse within our lifetime. Our social systems are already under strain, and the burden is becoming heavier. We have to do things better and we have to prevent whatever can be prevented.
Of the 2.7 billion that were committed under Europe’s Beating Cancer Plan, 2.1 went to research. We need to choose better where we invest our money. We need to tackle issues that can only be tackled on a European level.’
– Vlad Voiculescu MEP
With negotiations on the 2028 – 2034 EU budget under way and the current proposal putting dedicated health funding at risk, the timing could not be more important. ECO is calling for sustained, predictable investment in cancer control and a ring-fenced EU health programme.
Cancer control is one of the smartest investments Europe can make.”
You can also read: